Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?

Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?

A crucial complication after allogeneic hematopoietic cell transplantation (alloHCT), namely, acute graft-versus-host disease (aGVHD), occurs in about 50% of transplant recipients, leading to high morbidity and mortality. Thus far, the diagnosis of GVHD has been mainly established through clinical f...

Full description

Bibliographic Details
Main Authors: Vaia-Aikaterini Alexoudi, Eleni Gavriilaki, Angeliki Cheva, Ioanna Sakellari, Stavroula Papadopoulou, Konstantinos Paraskevopoulos, Konstantinos Vahtsevanos
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceuticals
Subjects:
biomarkers
GVHD
saliva
Online Access:https://www.mdpi.com/1424-8247/17/3/298

Similar Items

Similar Items